DFX Intelligence
Private Credit Intelligence
The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Borrower
O••••
Pharmaceuticals, Biotechnology and Life Sciencesgroup grade Bon a schedule nowsponsor unattributed
Also written as: O•••• Group
Principal held
at least $5.8M
sum of BDC pieces, a lower bound
Fair value
$6.7M
101c on cost, debt pieces
Unfunded
$5.0M
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Jun 30, 2028
$3.6M inside 24 months
On the tape since
Jun 30, 2025
latest Jun 30, 2026
Events
3
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien delayed draw term loan first lien | at least $3.6M | 102c | EURIBOR+600 bp | Jun 30, 2028 | 1 |
| first lien term loan first lien | at least $2.2M | 100c | EURIBOR+600 bp | Jun 30, 2032 | 1 |
| delayed draw term loan lien unstated exited Sep 30, 2025 | unknown | n/a | unstated | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C••••••• P•••••• C••••• I••••• C••• | delayed draw term loan first lien Investment Type Unitranche First Lien Delayed Draw Term Loan Interest Term E + 600 Interes | $3.6M | $4.1M 101c | EURIBOR+600 bp |
| C••••••• P•••••• C••••• I••••• C••• | delayed draw term loan first lien Investment Type Unitranche First Lien Delayed Draw Term Loan Maturity/ Dissolution Date 06 | n/a | n/a n/a | |
| C••••••• P•••••• C••••• I••••• C••• | delayed draw term loan first lien Investment Type Delayed Draw Term Loan Expiration Date 6/26/2028 | n/a | n/a | |
| C••••••• P•••••• C••••• I••••• C••• | delayed draw term loan first lien Investment Type Delayed Draw Term Loan One Expiration Date 6/26/2028 | n/a | n/a | |
| C••••••• P•••••• C••••• I••••• C••• | term loan first lien Investment Type Unitranche First Lien Term Loan Interest Term E + 600 Interest Rate 8.13% | $2.2M | $2.5M 100c | EURIBOR+600 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $5.8M | $6.7M | 101c | 0 |
| Mar 31, 2026 | 1 | $5.8M | $6.7M | 99c | 0 |
| Dec 31, 2025 | 1 | $3.9M | $3.9M | 102c | 0 |
| Sep 30, 2025 | 1 | $2.6M | $2.5M | 100c | 0 |
| Jun 30, 2025 | 1 | $2.6M | $2.5M | 100c | 0 |
What changed
- Maturity approachingJun 30, 2028
- Facility left every BDC scheduleSep 30, 2025
- New borrower on a BDC scheduleJun 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- OLYOSderivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 1 BDCderived
- Industry
- Pharmaceuticals, Biotechnology and Life Sciencesreportedas one filer wrote it